No Cover Image

Journal article 110 views 13 downloads

The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials / Lawrence A. Leiter; Steve Bain; Deepak L. Bhatt; John B. Buse; C. David Mazer; Richard E. Pratley; Søren Rasmussen; Maria Sejersten Ripa; Hrvoje Vrazic; Subodh Verma

Diabetes, Obesity and Metabolism

Swansea University Author: Steve, Bain

  • 54314VOR.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution‐NonCommercial License (CC-BY-NC).

    Download (728.43KB)

Check full text

DOI (Published version): 10.1111/dom.14079

Published in: Diabetes, Obesity and Metabolism
ISSN: 1462-8902 1463-1326
Published: Wiley 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa54314
Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: blood pressure, cardiovascular, liraglutide, MACE, semaglutide